Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
(RTTNews) - Pfizer Inc. (PFE) and Astellas Pharma U.S. Inc. announced final overall survival results from the Phase 3 EMBARK study evaluating XTANDI (enzalutami...
Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed antibody-drug conjuga...
Pharma titans Merck (MRK), Pfizer (PFE) and Astellas Pharma (ALPMY) are delivering an "enormous new hope" for patients with an aggressive form of bladder cancer...
Analyst ratings
60%
of 25 ratingsMore PFE News
New activity is brewing for Metsera, Inc. ( (MTSR) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gi...
Mixed options sentiment in Pfizer (PFE), with shares up 4c, or 0.19%, near $24.27. Options volume relatively light with 60k contracts traded and calls leading p...
President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockb...
Pfizer (PFE) stock recently moved slightly lower, with the share price closing at $24.23. Investors seem to be weighing Pfizer’s performance following modest re...
On October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV disclosed in an SEC filing that it sold out of Pfizer(PFE -0.72%), with an estimated $2.66 million tr...
On Thursday, QSM Asset Management disclosed a significant buy of Pfizer (PFE -0.02%), adding shares worth an estimated $6.8 million in the third quarter. What...
It's the best time in a while to scoop up shares of this stock from the discount bin. Over the past decade, pharmaceutical maker Pfizer (PFE -0.53%) has severe...
